Jefferies analyst Brian Tanquilut resumed coverage of Option Care Health with a Buy rating and $38 price target. The analyst says Option Care is positioned to deliver mid-teens EBITDA growth over the next few years and is poised to continue delivering positive earnings surprises given its "strong execution track record." The stock’s valuation does not reflect its growth outlook, the analyst tells investors in a research note.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on OPCH:
- 3 Stocks to Buy Today, 2/27/2023, According to Top Analysts
- Option Care Health sees 2023 revenue $4.15B-$4.375B, consensus $4.29B
- Option Care Health board authorizes $250M share repurchase plan
- Option Care Health reports Q4 EPS 26c, consensus 22c
- Option Care Health Reports Financial Results for Fourth Quarter and Full Year 2022 and Announces Share Repurchase Authorization